포스트 코로나증후군
Post-COVID-19 Syndrome
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Although acute COVID-19 usually lasts for 12 weeks from the onset of symptoms, some patients experience variable persistent symptoms. Post-COVID-19 syndrome is defined as persistent symptoms and/or long-term complications that appear during or after COVID-19, persist for more than 12 weeks, and cannot be explained by an alternative diagnosis. The common symptoms of post-COVID-19 syndrome include general, pulmonary, hematological, cardiovascular, neuropsychiatric, renal, endocrine, gastroenterological, and dermatological symptoms. As the natural course and pathophysiology of COVID-19 are not yet clear, close monitoring is needed for various sequelae in multiple organs that occur in post-COVID-19 syndrome. In particular, patients who have been hospitalized in the intensive care unit or who have recovered from severe COVID-19 require close monitoring for the development of post-COVID-19 syndrome. Multidisciplinary collaboration is essential to provide integrated outpatient care for patients with post-COVID-19 syndrome.
Abstract
Although acute COVID-19 usually lasts for 12 weeks from the onset of symptoms, some patients experience variable persistent symptoms. Post-COVID-19 syndrome is defined as persistent symptoms and/or long-term complications that appear during or after COVID-19, persist for more than 12 weeks, and cannot be explained by an alternative diagnosis. The common symptoms of post-COVID-19 syndrome include general, pulmonary, hematological, cardiovascular, neuropsychiatric, renal, endocrine, gastroenterological, and dermatological symptoms. As the natural course and pathophysiology of COVID-19 are not yet clear, close monitoring is needed for various sequelae in multiple organs that occur in post-COVID-19 syndrome. In particular, patients who have been hospitalized in the intensive care unit or who have recovered from severe COVID-19 require close monitoring for the development of post-COVID-19 syndrome. Multidisciplinary collaboration is essential to provide integrated outpatient care for patients with post-COVID-19 syndrome.
참고문헌 (43)
- Nalbandian A, "Post-acute COVID-19 syndrome", Nat Med, 27, pp.601~615 (2021)
- Carod-Artal FJ, "Post-COVID-19 syndrome : epidemiology, diagnostic criteria and pathogenic mechanisms involved", Rev Neurol, 72, pp.384~396 (2021)
- Moreno-Pérez O, "Post-acute COVID-19 syndrome. Incidence and risk factors:a Mediterranean cohort study", J Infect, 82, pp.378~383 (2021)
- Chopra V, "Sixty-day outcomes among patients hospitalized with COVID-19", Ann Intern Med, 174, pp.576~578 (2021)
- Carfì A, "Persistent symptoms in patients after acute COVID-19", JAMA, 324, pp.603~605 (2020)
- Carvalho-Schneider C, "Follow-up of adults with noncritical COVID-19 two months after symptom onset", Clin Microbiol Infect, 27, pp.258~263 (2021)
- Huang C, "6-month consequences of COVID-19 in patients discharged from hospital : a cohort study", Lancet, 397, pp.220~232 (2021)
- George PM, "Respiratory follow-up of patients with COVID-19 pneumonia", Thorax, 75, pp.1009~1016 (2020)
- Myall KJ, "Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment", Ann Am Thorac Soc, 18, pp.799~806 (2021)
- Patell R, "Postdischarge thrombosis and hemorrhage in patients with COVID-19", Blood, 136, pp.1342~1346 (2020)
- Agarwal AK, "Postural orthostatic tachycardia syndrome", Postgrad Med J, 83, pp.478~480 (2007)
- Lau ST, "Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS)", Int J Cardiol, 100, pp.167~169 (2005)
- Jabri A, "Incidence of stress cardiomyopathy during the coronavirus disease 2019 pandemic", JAMA Netw Open, 3, pp.e2014780~ (2020)
- Rajpal S, "Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection", JAMA Cardiol, 6, pp.116~118 (2021)
- Lang JP, "A current review of COVID-19 for the cardiovascular specialist", Am Heart J, 226, pp.29~44 (2020)
- Desai AD, "Management of arrhythmias associated with COVID-19", Curr Cardiol Rep, 23, pp.2~ (2020)
- Vaduganathan M, "Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19", N Engl J Med, 382, pp.1653~1659 (2020)
- Kociol RD, "Recognition and initial management of fulminant myocarditis : a scientific statement from the American Heart Association", Circulation, 141, pp.e69~e92 (2020)
- Bolay H, "COVID-19 is a real headache!", Headache, 60, pp.1415~1421 (2020)
- Garrigues E, "Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19", J Infect, 81, pp.e4~e6 (2020)
- Sakusic A, "Cognitive outcomes after critical illness", Curr Opin Crit Care, 24, pp.410~414 (2018)
- Ritchie K, "The cognitive consequences of the COVID-19 epidemic: collateral damage?", Brain Commun, 2, pp.fcaa069~ (2020)
- Kaseda ET, "Post-traumatic stress disorder : a differential diagnostic consideration for COVID-19 survivors", Clin Neuropsychol, 34, pp.1498~1514 (2020)
- Mazza MG, "Anxiety and depression in COVID-19 survivors : role of inflammatory and clinical predictors", Brain Behav Immun, 89, pp.594~600 (2020)
- Lee AM, "Stress and psychological distress among SARS survivors 1 year after the outbreak", Can J Psychiatry, 52, pp.233~240 (2007)
- Rogers JP, "Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic", Lancet Psychiatry, 7, pp.611~627 (2020)
- Taquet M, "Bidirectional associations between COVID-19 and psychiatric disorder : retrospective cohort studies of 62 354 COVID-19 cases in the USA", Lancet Psychiatry, 8, pp.130~140 (2021)
- Robbins-Juarez SY, "Outcomes for patients with COVID-19 and acute kidney injury: a systematic review and meta-analysis", Kidney Int Rep, 5, pp.1149~1160 (2020)
- Cummings MJ, "Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study", Lancet, 395, pp.1763~1770 (2020)
- Sharma P, "COVID-19-associated kidney injury : a case series of kidney biopsy findings", J Am Soc Nephrol, 31, pp.1948~1958 (2020)
- Golmai P, "Histopathologic and ultrastructural findings in postmortem kidney biopsy material in 12 patients with AKI and COVID-19", J Am Soc Nephrol, 31, pp.1944~1947 (2020)
- Peleg Y, "Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection", Kidney Int Rep, 5, pp.940~945 (2020)
- Jhaveri KD, "Thrombotic microangiopathy in a patient with COVID-19", Kidney Int, 98, pp.509~512 (2020)
- Suwanwongse K, "Newly diagnosed diabetes mellitus, DKA, and COVID-19: causality or coincidence? A report of three cases", J Med Virol, 93, pp.1150~1153 (2021)
- Brancatella A, "Subacute thyroiditis after Sars-COV-2 infection", J Clin Endocrinol Metab, 105, pp.dgaa276~ (2020)
- Salvio G, "Bone metabolism in SARS-CoV-2 disease : possible osteoimmunology and gender implications", Clin Rev Bone Miner Metab, 18, pp.51~57 (2020)
- Freeman EE, "The spectrum of COVID-19-associated dermatologic manifestations : an international registry of 716 patients from 31 countries", J Am Acad Dermatol, 83, pp.1118~1129 (2020)
- Mirza FN, "Dermatologic manifestations of COVID-19 : a comprehensive systematic review", Int J Dermatol, 60, pp.418~450 (2021)
- "Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C)" (2021)[URL]
- Feldstein LR, "Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-1", JAMA, 325, pp.1074~1087 (2021)
- Jiang L, "COVID-19 and multisystem inflammatory syndrome in children and adolescents", Lancet Infect Dis, 20, pp.e276~e288 (2020)
- Rowley AH, "Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children", Nat Rev Immunol, 20, pp.453~454 (2020)
- McCrindle BW, "Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association", Circulation, 135, pp.e927~e999 (2017)